Loading clinical trials...
Loading clinical trials...
This is an open-label study to evaluate the pharmacokinetics, safety and tolerability of single oral doses of Alisporivir in subjects with mild and moderate hepatic impairment compared to matched heal...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Debiopharm International SA
NCT07343037 · Hepatic Insufficiency, Cirrhosis, Liver
NCT07165002 · Healthy, Hepatic Insufficiency
NCT07345689 · Hepatic Insufficiency, Renal Insufficiency, and more
NCT05209295 · Hepatic Insufficiency, Neoplasms
NCT05661344 · Hepatic Insufficiency
University of Miami
Miami, Florida
Orlando Clinical Research Center
Orlando, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions